3Labonte MJ,Manegold PC,Wilson PM. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38[J].International Journal of Cancer,2009,(12):2957-2969. 被引量：1
4Koizumi W,Narahara H,Hara T. S-1 plus cisplatin holds promise of becoming a standard first-line treatment for patients with advanced gastric cancer(SPIRITS trail):a phase III trial[J].Lancet Oncology,2008,(03):215-221. 被引量：1
5Claus Schildberg,R. Croner,S. Merkel,V. Schellerer,V. Müller,S. Yedibela,W. Hohenberger,G. Peros,A. Perrakis.Outcome of Operative Therapy of Hepatic Metastatic Stomach Carcinoma: A Retrospective Analysis[J]. World Journal of Surgery . 2012 (4) 被引量：2
6Yves Dittmar,Annelore Altendorf-Hofmann,Falk Rauchfuss,Max G?tz,Hubert Scheuerlein,Karin Jandt,Utz Settmacher.Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature[J]. Gastric Cancer . 2012 (2) 被引量：1
7Yoichi Hamai,Jun Hihara,Manabu Emi,Yoshiro Aoki,Kei Kushitani,Kazuaki Tanabe,Morihito Okada.Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report. BMC Gastroenterology . 2012 被引量：1
